title: Caspofungin.
abstract: Caspofungin is a new antifungal drug meant for intravenous use. It has been shown to be comparable to other antifungal agents such as amphotericin B and fluconazole for empirical therapy in febrile neutropenic patients, oropharyngeal/esophageal candidiasis and invasive aspergillosis. Its efficacy has also been documented in children in small uncontrolled trials. The biggest assets of caspofungin are its excellent tolerability/safety profile and minimal drug interactions.
authors.affiliation: Department of Pediatrics, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India.
authors.forename: Ankit
authors.initials: A
authors.lastname: Parakh
authors.forename: Anand Prakash
authors.initials: AP
authors.lastname: Dubey
authors.forename: Debopam
authors.initials: D
authors.lastname: Samanta
mesh_terms: D000771:Anesthesia, Intravenous; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy; D000077336:Caspofungin; D054714:Echinocandins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D055666:Lipopeptides; D009181:Mycoses / Q000188:drug therapy*
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077336:Caspofungin